Next Generation News and Research

RSS

New review shows why antidepressants often fail in Alzheimer’s and Parkinson’s depression

A Molecular Psychiatry review shows that depression in Alzheimer’s and Parkinson’s disease may reflect disease-specific molecular, neurotransmitter, inflammatory, and circuit-level disruptions rather than standard depression biology alone. It argues that broad antidepressants often show limited efficacy in these patients and that future trials should use biomarkers, neuroimaging, and symptom profiling to guide targeted treatments.

7 Jul 2026

USC researcher wins NIH grant to study how the cochlea processes complex sounds

USC researcher Karolina Charaziak, PhD, has been awarded a $3.3 million National Institutes of Health (NIH) Research Project (R01) grant to study how the cochlea, the part of the inner ear responsible for hearing, processes complex sounds encountered in everyday life.

7 Jul 2026

New Mount Sinai center focuses on advancing personalized treatments for peanut allergy

Researchers at the Icahn School of Medicine at Mount Sinai have been awarded a five-year, $7.2 million grant from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to establish a new Asthma and Allergic Diseases Cooperative Research Center focused on advancing personalized treatment strategies for peanut allergy.

7 Jul 2026

Eppendorf focuses outreach programs to advance STEM education in Europe

Eppendorf, a leading international life science company that develops, manufactures, and distributes instruments, consumables, and services for use in laboratories around the world, today highlights its European outreach activities dedicated to addressing persistent challenges in STEM education.

From Eppendorf 7 Jul 2026

Memory B cells reveal how nasal vaccines could stop respiratory infections earlier

A Science Immunology Review explains how memory B cells acquire diverse molecular, epigenetic, and tissue-specific programs that shape long-term immune protection. It highlights lung-resident memory B cells as a key target for mucosal vaccines, potentially improving control of airborne infections and reducing transmission.

6 Jul 2026

MGI Tech showcases expanding genomics ecosystem at ESHG 2026 with new IVD partnering program and OEM collaborations

At ESHG 2026, MGI Tech presents cutting-edge genomics solutions, emphasizing automation and partnerships to enhance clinical workflows and precision medicine.

From MGI 6 Jul 2026

New genome editing tool unlocks fungi's hidden drug-producing potential

Researchers have spent decades-and billions of dollars-sequencing animal and crop genomes, but fungi have historically been the forgotten middle child of genomics, only noticed when they're ruining bread or colonizing toes.

2 Jul 2026

New grants advance AI-powered wastewater pathogen surveillance

Detecting infectious disease threats early and responding quickly can dramatically alter the course of an infectious outbreak.

2 Jul 2026

Study potential new therapeutic strategy for patients with ATRX-mutant gliomas

A new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of the most common genetic alterations in glioma rewires the cancer cell genome to fuel tumor progression, suggesting a potential new therapeutic strategy for patients with ATRX-mutant gliomas.

1 Jul 2026

UTSA researchers develop bait pellets to combat Lyme disease

A breakthrough in the fight against Lyme disease is moving from the laboratory to the hardware store.

30 Jun 2026

Scientists capture atomic images to improve RNA interference drug design

RNA interference is a natural mechanism for living cells to control whether specific genes are being used or not.

29 Jun 2026

Under-twos should avoid screen time to protect future health

Using screens during the first 1001 days of life can lead to developmental concerns for the next generation, researchers warn.

29 Jun 2026

Merck KGaA, Darmstadt, Germany, agrees to acquire Bio-Techne, strengthening leadership position in fast-growing life sciences markets

Merck KGaA, Darmstadt, Germany, a leading science and technology company, and Bio-Techne Corporation, a Minneapolis-based global provider of life science tools, analytical technologies, and consumables, today entered into a definitive agreement pursuant to which Merck KGaA, Darmstadt, Germany, will, subject to customary closing conditions, acquire Bio-Techne for US$73 per share in cash, representing a total enterprise value of approximately US$11.3 billion (EUR 9.9 billion), a 36% premium to Bio-Techne's one-month volume weighted average trading price.

From Bio-Techne 25 Jun 2026

Review outlines key strategies to overcome antibody drug conjugate resistance

The first Antibody-drug conjugate (ADC) was approved overa quarter-century ago, and today more than 20 have reached the clinic.

24 Jun 2026

Scientists unlock molecular structure of key protein linked to cancer, neurological diseases

After nearly four decades of research, Mayo Clinic scientists have revealed the molecular structures of protein kinase C beta (PKCβ), a key protein linked to cancer and neurological diseases.

23 Jun 2026

Natural molecule erucamide helps slow progressive retinal degeneration

Many conditions that cause vision loss share a common feature: the gradual breakdown of the retina, the light-sensing tissue at the back of the eye.

22 Jun 2026

How electrical engineering ensures accurate calibration and patient safety

Discover how electrical engineering supports calibration accuracy, device reliability, and patient safety in critical healthcare applications.

From Mesa Labs, Inc. 22 Jun 2026

International survey highlights major gaps in cardio-oncology education

An international survey has highlighted major gaps in cardio-oncology training, despite its increasing clinical importance. These results were presented at ESC Cardio-Oncology 2026, the second annual conference of the European Society of Cardiology's Council of Cardio-Oncology.

21 Jun 2026

Synthetic gut communities reveal how diet rewires the microbiome

Synthetic microbial communities give researchers controlled models for testing how diet reshapes gut microbial ecology, metabolism, and host-relevant responses. The review highlights how SynComs can strengthen causal inference, improve intervention testing, and support future precision nutrition, while noting major challenges in stability, standardization, and ecological realism.

21 Jun 2026

New optical technique uses light to reveal internal contents of chicken eggs

Scientists have demonstrated a non-invasive technique that uses light to reveal the hidden contents of chicken eggs, potentially helping to curb the meat industry's practice of killing billions of male chicks at birth.

19 Jun 2026